Connecticut 2025 2025 Regular Session

Connecticut House Bill HB06433 Comm Sub / Analysis

Filed 03/10/2025

                     
Researcher: MK 	Page 1 	3/10/25 
 
 
 
OLR Bill Analysis 
sHB 6433  
 
AN ACT CONCERNING CAPTIVE INSURANCE.  
 
SUMMARY 
This bill makes various changes in laws related to captive insurers 
(see BACKGROUND) by generally allowing: 
1. a captive insurance company domiciled in the state, with the 
insurance commissioner’s prior written approval, to convert into 
a protected cell; 
2. a sponsored captive insurance company, with prior consent of 
certain relevant entities and the commissioner’s approval, to sell, 
transfer, assign, or otherwise convey a protected cell to a new or 
existing sponsored captive insurance company or one licensed as 
a special purpose financial insurance company; and 
3. the insurance commissioner to separate any insolvent protected 
cell from the sponsored captive insurance company, and the 
insolvent protected cell to convert into a new protected cell or a 
captive insurance company. 
It also subjects captive insurance companies to the general penalty 
under existing law if they violate any provision of the insurance title for 
which no other penalty is provided. By law, this general penalty is a fine 
up to $15,000. 
EFFECTIVE DATE: October 1, 2025 
CONVERSION TO PROTECTED CELL 
Eligibility 
The bill allows any captive insurance company domiciled in the state 
to convert into a protected cell if it (1) is organized as an agency captive 
insurance company, association captive insurance company, industrial  2025HB-06433-R000063-BA.DOCX 
 
Researcher: MK 	Page 2 	3/10/25 
 
insured captive insurance company, pure captive insurance company, 
risk retention group, or special purpose financial insurance company 
and (2) has the commissioner’s prior written approval. 
Laws That Govern the Conversion 
The captive insurance company must perform the conversion under 
the laws applicable to business corporations, limited liability 
companies, or any other type of legal entity allowed under state law, as 
applicable. 
Effect of the Conversion 
Under the bill, the conversion is subject to the captive insurance-
related statutes and the captive insurance company’s plan of operation 
approved by the commissioner, but it does not affect the converted 
captive insurance company’s assets, rights, benefits, obligations, or 
liabilities. 
The bill deems the captive insurance company’s conversion into a 
protected cell to be a continuation of the company’s existence with all 
its assets, rights, benefits, obligations, and liabilities as a protected cell. 
The conversion occurs without transferring, assigning, impairing, or 
creating a reversionary interest in the captive insurance company’s 
assets, rights, benefits, obligations, or liabilities.  
The bill specifies that a captive insurance company’s conversion does 
not limit any of the rights or protections that the company had under 
certain laws relating to its licensure as a captive insurance company 
before the conversion. 
CONVEYANCE OF PROTEC TED CELL 
Eligibility 
The bill allows any sponsored captive insurance company, including 
those licensed as a special purpose financial insurance company, to sell, 
transfer, assign or otherwise convey a protected cell, together with all of 
the protected cell’s assets, rights, benefits, obligations, and liabilities, to 
a new or existing sponsored captive insurance company or one licensed 
as a special purpose financial insurance company. The company must  2025HB-06433-R000063-BA.DOCX 
 
Researcher: MK 	Page 3 	3/10/25 
 
do so according to any plan of operation approved by the commissioner. 
Prerequisites 
Under the bill, to convey the protected cell as described above, the (1) 
company must get (a) the affected incorporated protected cell’s consent 
or (b) prior consent from each participant of the affected protected cell 
or as otherwise allowed under a participation agreement, (2) sponsor 
must file an application, and (3) commissioner must approve in writing. 
Effect of the Sale, Transfer, Assignment, or Conveyance 
The bill deems any sale, transfer, assignment, or conveyance of a 
protected cell (as described above) as a continuation of the protected 
cell’s existence, with all its assets, rights, benefits, obligations, and 
liabilities, as a protected cell of the transferee sponsored captive 
insurance company. 
Under the bill, the sale, transfer, assignment, or conveyance of a 
protected cell does not limit any rights or protections that the 
transferred protected cell and the transferor sponsored captive 
insurance company or sponsored captive insurance company licensed 
as a special purpose financial insurance company had under applicable 
insurance laws immediately before the sale, transfer, assignment, or 
conveyance date. 
SEPARATION OF INSOLVENT PROTECTED CELL  
The bill allows the (1) insurance commissioner to separate any 
insolvent protected cell from the sponsored captive insurance company 
and (2) insolvent protected cell to convert into a captive insurance 
company or a new protected cell of another sponsored captive insurance 
company. 
The bill deems the conversion of the insolvent protected cell as a 
continuation of its existence as a new protected cell or captive insurance 
company, as applicable. Under the bill, the conversion occurs without 
transferring, assigning, impairing, or creating a reversionary interest in 
the protected cell’s assets, rights, benefits, obligations, or liabilities.  
  2025HB-06433-R000063-BA.DOCX 
 
Researcher: MK 	Page 4 	3/10/25 
 
BACKGROUND 
Captive Insurers 
Generally, a captive insurer is an insurance company formed to 
insure or reinsure the risks of its owners, parent company, or affiliated 
company. Existing law allows several different types of captive insurers 
to be licensed and operate in the state. One type, a sponsored captive 
insurer, is an insurance company that (1) has the minimum paid-in 
capital and surplus provided by one or more sponsors, (2) insures its 
participants through separate participant contracts, and (3) funds its 
liability to each participant through protected cells and separates each 
cell’s assets from that of other cells and the captive insurer as a whole.  
COMMITTEE ACTION 
Insurance and Real Estate Committee 
Joint Favorable Substitute 
Yea 13 Nay 0 (02/20/2025)